These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23393492)

  • 1. Lipid-like Nanoparticles for Small Interfering RNA Delivery to Endothelial Cells.
    Cho SW; Goldberg M; Son SM; Xu Q; Yang F; Mei Y; Bogatyrev S; Langer R; Anderson DG
    Adv Funct Mater; 2009 Oct; 19(19):3112-3118. PubMed ID: 23393492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.
    de Groot AM; Thanki K; Gangloff M; Falkenberg E; Zeng X; van Bijnen DCJ; van Eden W; Franzyk H; Nielsen HM; Broere F; Gay NJ; Foged C; Sijts AJAM
    Mol Ther Nucleic Acids; 2018 Jun; 11():159-169. PubMed ID: 29858051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery.
    Jiang S; Eltoukhy AA; Love KT; Langer R; Anderson DG
    Nano Lett; 2013 Mar; 13(3):1059-64. PubMed ID: 23394319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles.
    Wang M; Alberti K; Varone A; Pouli D; Georgakoudi I; Xu Q
    Adv Healthc Mater; 2014 Sep; 3(9):1398-403. PubMed ID: 24574196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of small interfering RNA for inhibition of endothelial cell apoptosis by hypoxia and serum deprivation.
    Cho SW; Hartle L; Son SM; Yang F; Goldberg M; Xu Q; Langer R; Anderson DG
    Biochem Biophys Res Commun; 2008 Nov; 376(1):158-63. PubMed ID: 18765230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial Synthesis of a Lipidoid Library by Thiolactone Chemistry:
    Molla MR; Chakraborty S; Munoz Sagredo L; Drechsler M; Orian Rousseau V; Levkin PA
    Bioconjug Chem; 2020 Mar; 31(3):852-860. PubMed ID: 32068393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model.
    Ball RL; Knapp CM; Whitehead KA
    PLoS One; 2015; 10(7):e0133154. PubMed ID: 26192592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
    Thanki K; Zeng X; Foged C
    Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis.
    Han X; Gong N; Xue L; Billingsley MM; El-Mayta R; Shepherd SJ; Alameh MG; Weissman D; Mitchell MJ
    Nat Commun; 2023 Jan; 14(1):75. PubMed ID: 36650129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.
    Lokras A; Thakur A; Wadhwa A; Thanki K; Franzyk H; Foged C
    Front Bioeng Biotechnol; 2020; 8():601155. PubMed ID: 33520957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial Library of Light-Cleavable Lipidoid Nanoparticles for Intracellular Drug Delivery.
    Li Y; Chakraborty A; Chen J; Xu Q
    ACS Biomater Sci Eng; 2019 May; 5(5):2391-2398. PubMed ID: 33405747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA Delivery Using Bioreducible Lipidoid Nanoparticles Facilitates Neural Differentiation of Human Mesenchymal Stem Cells.
    Zhao X; Glass Z; Chen J; Yang L; Kaplan DL; Xu Q
    Adv Healthc Mater; 2021 Feb; 10(4):e2000938. PubMed ID: 32815325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery.
    Nguyen DN; Mahon KP; Chikh G; Kim P; Chung H; Vicari AP; Love KT; Goldberg M; Chen S; Krieg AM; Chen J; Langer R; Anderson DG
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):E797-803. PubMed ID: 22421433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection.
    Ma F; Yang L; Sun Z; Chen J; Rui X; Glass Z; Xu Q
    Sci Adv; 2020 Jul; 6(30):eabb4429. PubMed ID: 32832671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.